About SENSORIUM THERAPEUTICS, INC.
Sensorium is a clinical-stage biotech developing first-in-class CNS therapies guided by human biology and natural neuroactive patterns. The company focuses on anxiety, epilepsy, and cognitive dysfunction with programs like SENS-01, SENS-03, and SENS-08.
Development of first-in-class CNS therapiesIntegration of natural product data, AI tools, and chemical analysis through SensAI platformDrug discovery informed by human biology and ethnobotanical recordsPreclinical and clinical development of novel compounds for CNS disorders
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SENSORIUM THERAPEUTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.